Veracyte, Quotient Limited Lead Gainers as 360Dx Index Inches Up 1 Percent in November

NEW YORK – November was a mixed month for the stocks of many diagnostics firms as the 360Dx Index rose about 1 percent from October.

Of the 32 companies in the Index, seven firms saw their share prices drop last month paced by Quidel (-27 percent) and Accelerate Diagnostics (-17 percent). Meanwhile, 25 companies' stock prices rose, led by Veracyte (+57 percent), Quotient Limited (+47 percent), and Myriad Genetics (+41 percent).